Aloe Liquid Extract—Darnitsa Liquid Extract for Injection, 1 mL, No. 10, in ampoules
Ingredients
Active ingredient: aloes extractum siccum;
1 mL of extract contains 2.25 mg of dry aloe extract (aloes extractum siccum), calculated as 100% calcium and magnesium salts of organic acids in the dry matter;
excipients: sodium chloride, water for injection.
Dosage Form
Liquid extract for injection.
Main physical and chemical properties: a light yellow to brownish-yellow liquid with a faint characteristic odor. The presence of a suspension is permitted in the preparation; during storage, it precipitates, forming a uniform suspension when the ampules are shaken.
Pharmacotherapeutic group
Agents affecting the digestive system and metabolic processes. ATC code A16A X.
Pharmacological Properties
Pharmacodynamics.
Biogenic stimulant. Exerts adaptogenic and general tonic effects. Improves cellular metabolism, tissue trophism, and regeneration; increases the body’s general nonspecific resistance and the resistance of mucous membranes to damaging agents. Stimulates the protective functions of granulocytes and increases appetite. Increases energy reserves in spermatozoa and enhances their motility.
Pharmacokinetics.
Not studied.
Indications
Progressive myopia, myopic chorioretinitis, blepharitis, conjunctivitis, keratitis, iritis, vitreous opacity, as well as gastric and duodenal ulcers (as part of combination therapy).
Contraindications
Hypersensitivity to the drug. Severe cardiovascular diseases, hypertension, acute gastrointestinal disorders (including diarrhea), intestinal obstruction, Crohn’s disease, ulcerative colitis, appendicitis, abdominal pain of unknown origin, hemorrhoids, impaired liver/kidney function, complicated forms of nephrosis-nephritis, diffuse glomerulonephritis, cystitis, metrorrhagia, hemoptysis, cholelithiasis.
Interactions with Other Medications and Other Types of Interactions
Enhances the effects of agents that stimulate hematopoiesis and iron preparations. Concomitant use of aloe extract with thiazide diuretics, loop diuretics, licorice preparations, or corticosteroids increases the risk of potassium deficiency.
Special Instructions for Use
To prevent pain, 0.5 mL of 2% novocaine may be injected into the intended injection site beforehand.
Use during pregnancy or breastfeeding.
Do not use this medication, as its mechanism of action (as a biogenic stimulant) has not been sufficiently studied.
Effect on reaction time when operating motor vehicles or other machinery.
Not studied.
Dosage and Administration
If sediment is present, shake the ampule before opening until a uniform suspension forms.
Administer aloe extract subcutaneously daily: adults—1 mL (maximum daily dose—3–4 mL); children aged 3 to 5 years: 0.2–0.3 mL; children aged 5 years and older: 0.5 mL. The course of treatment consists of 30–50 injections. Repeat courses should be administered after a 2- or 3-month break.
Children.
Use in children aged 3 years and older.
Overdose
No cases of overdose with this medication have been reported. Side effects may be more pronounced.
Side Effects
Gastrointestinal: a scratchy sensation, dyspepsia, abdominal pain.
Cardiovascular system: increased blood pressure.
Immune system: allergic reactions, including flushing, itching, rash, and hives.
General disorders and administration site conditions: dizziness, sensation of blood rushing to the pelvic organs, increased menstrual bleeding, burning sensation, hyperthermia, changes at the injection site, including erythema and itching.
Shelf life
3 years.
Storage conditions
Store out of reach of children in the original packaging at a temperature not exceeding 25 °C. Do not freeze.
Incompatibility
This medication must not be mixed with other medications.
Packaging
1 mL per ampoule; 5 ampoules per blister pack; 2 blister packs per carton.
Dispensing Category
By prescription only.
Manufacturer
PJSC “Darnitsa Pharmaceutical Company.”
Similar products
Products from the same category












